Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "AREA[SponsorSearch](Sage Therapeutics)"
Count: 46
Selected: 0
NCT IDTitle
NCT05366751A Study to Evaluate the Long-term Safety and Tolerability of SAGE-324 in Participants With Essential Tremor
NCT05358821A Study to Evaluate the Effect of SAGE-718 on Functioning Capacity in Participants With Huntington's Disease
NCT05318937A Study to Evaluate the Effects of SAGE-718 in Participants With Parkinson's Disease Cognitive Impairment
NCT05173012Study to Evaluate SAGE-324 in Participants With Essential Tremors
NCT05107128A Study to Evaluate the Effect of SAGE-718 on Cognitive Function in Participants With Huntington's Disease (HD)
NCT05059600A Study To Assess The Safe-Use Conditions For Administration of ZULRESSO® in a Home Setting
NCT05049343Study of SAGE-904 Using a Ketamine Challenge to Evaluate Electrophysiology, Safety, Tolerability, and Pharmacokinetics in Healthy Participants
NCT04602624A Study to Evaluate the Safety and Tolerability of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (AD)
NCT04537806A Study of Brexanolone for Acute Respiratory Distress Syndrome (ARDS) Due to Coronavirus Disease 2019 (COVID-19)
NCT04476030A Comparative Study of Sage-217 Plus an Antidepressant (ADT) Versus Placebo Plus an ADT in Adults With Major Depressive Disorder
NCT04476017A Study to Evaluate the Safety and Tolerability of SAGE-718 in Participants With Parkinson's Disease Mild Cognitive Impairment (PD-MCI)
NCT04442503A Study to Evaluate the Efficacy and Safety of SAGE-217 in Participants With Severe Postpartum Depression (PPD)
NCT04442490A Study to Evaluate the Efficacy of Sage-217 in the Treatment of Adult Participants With Major Depressive Disorder (MDD)
NCT04305275A Study to Evaluate the Efficacy, Safety, and Tolerability of SAGE-324 in Participants With Essential Tremor
NCT04273191A Study to Evaluate Multimodal Neuroimaging Parameters in Women With Postpartum Depression Who Are Receiving ZULRESSO™ (Brexanolone)
NCT04007367A Study to Evaluate SAGE-217 for Prevention of Relapse in Adult Subjects With Major Depressive Disorder
NCT03924492Expanded Access Protocol of ZULRESSO™ (Brexanolone) Injection for Adult Patients With Postpartum Depression
NCT03864614A Study to Evaluate SAGE-217 in Adult Participants With Major Depressive Disorder (MDD)
NCT03844906A Study to Assess Electrophysiology, Safety, Tolerability, and Pharmacokinetics of Multiple Doses of SAGE-718 Using Ketamine Challenge in Healthy Subjects
NCT03787758A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of SAGE-718 Oral Solution in Patients With Huntington's Disease - Part B
NCT03771664A Study to Evaluate the Safety, Tolerability, and Efficacy of SAGE-217 Compared to Placebo in Adult Subjects With Comorbid Major Depressive Disorder and Insomnia
NCT03771586A Study to Assess the Electrophysiology, Safety, Tolerability, and Pharmacokinetics of SAGE-718 Using a Ketamine Challenge in Healthy Subjects
NCT03770780A Study to Assess the Electrophysiology, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Response Using Magnetic Resonance Imaging of SAGE-718 Using a Ketamine Challenge in Healthy Subjects
NCT03692910A Study to Evaluate SAGE-217 in Participants With Bipolar I/II Disorder With a Current Major Depressive Episode
NCT03672175A Study to Evaluate the Efficacy of SAGE-217 in the Treatment of Adult Subjects With Major Depressive Disorder
NCT03665038A Study to Assess the Safety of Brexanolone in the Treatment of Adolescent Female Participants With Postpartum Depression (PPD)
NCT03284931A Study to Assess the Pharmacodynamic Effects of SAGE-217 in Healthy Adults Using an Insomnia Model
NCT03000569A Study to Evaluate SAGE-217 in Participants With Parkinson's Disease
NCT03000530A Study to Evaluate SAGE-217 in Participants With Moderate to Severe Major Depressive Disorder
NCT02978781A Study to Evaluate SAGE-217 in Participants With Essential Tremor
NCT02978326A Study to Evaluate SAGE-217 in Participants With Severe Postpartum Depression
NCT02942017A Study to Evaluate Safety and Efficacy of SAGE-547 in Participants With Moderate Postpartum Depression (547-PPD-202C)
NCT02942004A Study to Evaluate Efficacy and Safety of SAGE-547 in Participants With Severe Postpartum Depression (547-PPD-202B)
NCT02614547A Study to Evaluate SAGE-547 in Participants With Severe Postpartum Depression
NCT02477618A Study With SAGE-547 for Super-Refractory Status Epilepticus
NCT02433314An Open Label, Expanded Access Protocol With SAGE-547 for Super-Refractory Status Epilepticus
NCT02285504Evaluate SAGE-547 in Female Participants With Severe Postpartum Depression
NCT02277106Evaluate SAGE-547 in Participants With Essential Tremor
NCT02052739Study to Evaluate SAGE-547 Injection as Adjunctive Therapy for the Treatment of Super-Refractory Status Epilepticus
NCT05314153Effects Zulresso on Postpartum Psychosis
NCT05254405An Open Label Pilot Study of IV Brexanolone for the Treatment of Post-Traumatic Stress Disorder
NCT05543746Dynamic Neural Mechanisms of Brexanolone-induced Antidepressant Effects in Postpartum Depression
NCT05223829Utility of Brexanolone to Target Stress-induced Alcohol Use Among Men and Women With Posttraumatic Stress Disorder
NCT01246765National Pregnancy Registry for Atypical Antipsychotics
NCT04025502Event-Related Potential (ERP) Biomarkers in Subjects With Schizophrenia and Healthy Volunteer Subjects
NCT04928703Effects of Ketamine on ERP/EEG Measures in Healthy Volunteers